[go: up one dir, main page]

IN192750B - - Google Patents

Info

Publication number
IN192750B
IN192750B IN1170DE2000A IN192750B IN 192750 B IN192750 B IN 192750B IN 1170DE2000 A IN1170DE2000 A IN 1170DE2000A IN 192750 B IN192750 B IN 192750B
Authority
IN
India
Application number
Inventor
Deepak Murpani
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN1170DE2000 priority Critical patent/IN192750B/en
Priority to AU2002220968A priority patent/AU2002220968A1/en
Priority to PCT/IB2001/002354 priority patent/WO2002047607A2/en
Priority to EP01270300A priority patent/EP1343481A4/en
Publication of IN192750B publication Critical patent/IN192750B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
IN1170DE2000 2000-12-15 2000-12-15 IN192750B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN1170DE2000 IN192750B (en) 2000-12-15 2000-12-15
AU2002220968A AU2002220968A1 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form
PCT/IB2001/002354 WO2002047607A2 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form
EP01270300A EP1343481A4 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1170DE2000 IN192750B (en) 2000-12-15 2000-12-15

Publications (1)

Publication Number Publication Date
IN192750B true IN192750B (en) 2004-05-15

Family

ID=11097139

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1170DE2000 IN192750B (en) 2000-12-15 2000-12-15

Country Status (4)

Country Link
EP (1) EP1343481A4 (en)
AU (1) AU2002220968A1 (en)
IN (1) IN192750B (en)
WO (1) WO2002047607A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (en) 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
KR100503949B1 (en) * 2003-04-28 2005-07-26 주식회사유한양행 A composition of fast dissolving tablets effectively masked bitter taste of ondansetron hydrochloride
FR2858556B1 (en) * 2003-08-06 2006-03-10 Galenix Innovations DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
ES2633449T3 (en) 2007-10-31 2017-09-21 Johnson & Johnson Consumer Inc. Orally disintegrable dose form
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102258497B (en) * 2011-08-18 2013-01-09 海南良方医药有限公司 Lamivudine tablet composition and preparation method thereof
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103432091A (en) * 2013-09-13 2013-12-11 钟术光 Improved-performance tablet and preparation method thereof
CA2936216C (en) 2014-01-10 2021-10-26 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN113490486B (en) 2019-02-22 2025-10-17 康特伦英国斯温顿捷迪斯有限公司 Minimizing agglomeration, aeration and maintaining a coating of a pharmaceutical composition comprising ibuprofen
AR118418A1 (en) 2019-02-22 2021-10-06 Catalent Uk Swindon Zydis Ltd PRESERVATION OF FUNCTIONALLY COATED IFA PARTICLES PRODUCED THROUGH SOLVENT-FREE MIXING PROCESSES IN AQUEOUS SUSPENSION
MX2021009681A (en) 2019-02-22 2021-09-10 Catalent Uk Swindon Zydis Ltd MINIMIZATION OF AERATION OF SUSPENSIONS DURING IN-LINE MIXING.
KR20210130722A (en) 2019-02-22 2021-11-01 카탈렌트 유.케이. 스윈던 지디스 리미티드 Minimize agglomeration of drug particle coating material during storage to stabilize disintegration time of drug product
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
PL3962455T3 (en) 2020-05-18 2023-01-16 Orexo Ab New pharmaceutical composition for drug delivery
TW202220638A (en) 2020-07-31 2022-06-01 英商康泰倫特英國斯文敦載迪斯有限公司 Pharmaceutical compositions comprising coated api
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
CA3238850A1 (en) 2021-11-25 2023-06-01 Jonas Savmarker Pharmaceutical composition comprising adrenaline

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115830A (en) * 1984-06-28 1986-01-23 ザ　プロクタ−　アンド　ガンブル　カンパニ− Antacid composition and manufacture
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
JP3233638B2 (en) * 1993-07-09 2001-11-26 アール．ピー． シェーラー コーポレイション Method for producing freeze-dried drug dosage forms
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
DK0893992T3 (en) * 1996-04-16 2004-06-01 Novartis Consumer Health Sa Rapidly decomposing oral dosage form
AU2640599A (en) * 1998-02-26 1999-09-15 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
GT199900061A (en) * 1998-05-15 2000-10-14 Pfizer PHARMACEUTICAL FORMULATIONS.

Also Published As

Publication number Publication date
AU2002220968A1 (en) 2002-06-24
EP1343481A2 (en) 2003-09-17
EP1343481A4 (en) 2004-03-17
WO2002047607A2 (en) 2002-06-20
WO2002047607A3 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
BRPI0113085B8 (en)
JP2000322826A5 (en)
JP2003513570A5 (en)
JP2001188514A5 (en)
JP2001108994A5 (en)
IN192750B (en)
JP2001201710A5 (en)
JP2003502930A5 (en)
JP2002044727A5 (en)
JP2001171249A5 (en)
HU0004446D0 (en)
JP2001231657A5 (en)
CH694022C1 (en)
JP2003518093A5 (en)
JP2002137712A5 (en)
JP2001355192A5 (en)
JP2002127453A5 (en)
HU0004593D0 (en)
CN3144127S (en)
CN3141398S (en)
CN3145162S (en)
CN3145103S (en)
CN3144928S (en)
CN3144322S (en)
CN3145854S (en)